Newswise — SAN FRANSISCO, CA – Five additional studies of note are among those that will be presented at the 2013 Breast Cancer Symposium, taking place September 7-9, 2013 at the San Francisco Marriott Marquis in San Francisco, California. Two studies examine cognitive function in women who undergo treatment for early-stage breast cancer; a third evaluates impact of tumor genotyping on clinical trial enrollment; and the final two evaluate the outcomes of different treatment approaches.
Saturday, September 7 Presentations
Abstract #48:Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy (NCT) and analysis of survival outcome.
General Poster Session ASaturday, September 7, 2013, 11:30 AM – 1:00 PM PSTSaturday, September 7, 2013, 4:30 PM – 6:00 PM PSTGolden Gate Hall
Napa Parinyanitikul, MDThe University of Texas MD Anderson Cancer CenterHouston, TX
Abstract # 55:Ten-year outcomes of accelerated partial breast irradiation compared with whole breast irradiation: A matched-pair analysis.
Poster Discussion A Saturday, September 7, 2013, 4:00 PM – 4:20 PM PSTYerba Buena Ballroom, Salon 8 Jessica Wobb, MDOakland University William Beaumont School of Medicine, Beaumont Cancer Institute Royal Oak, MI
Sunday, September 8 Presentations
Abstract # 105:Prospective study of cognitive function (cog fcn) in women with early-stage breast cancer (BC): Relationship between perceived and measurable cognitive deficits.
Poster Discussion B Sunday, September 8, 2013, 3:00 PM – 3:20 PM PSTYerba Buena Ballroom, Salon 8
Lara Heflin, PhDNew Mexico Highlands UniversityLas Vegas, NM
Abstract # 104:Prospective study of cognitive function (cog fcn) in women with early-stage breast cancer (ESBC): Predictors of cognitive decline.
Poster Discussion B Sunday, September 8, 2013, 3:00 PM – 3:20 PM PSTYerba Buena Ballroom, Salon 8
Hope S. Rugo, MDUCSF Helen Diller Family Comprehensive Cancer CenterSan Francisco, CA
Abstract # 145:Impact of routine tumor genotyping on enrollment in targeted therapy trials for metastatic breast cancer (MBC): 4-year review.
Poster Discussion B Sunday, September 8, 2013, 4:00 PM – 4:20 PM PSTYerba Buena Ballroom, Salon 8
Aditya Bardia, MDMassachusetts General Hospital, Harvard Medical School Boston, MA
Click here to view the full tip sheet.
2013 Breast Cancer Symposium News Planning TeamDennis R. Holmes, M.D., FACS, American Society of Breast Disease (ASBD); Deanna J. Attai, MD, FACS, The American Society of Breast Surgeons; Steven O’Day, MD, American Society of Clinical Oncology (ASCO); Bruce G. Haffty, MD, FASTRO, American Society for Radiation Oncology (ASTRO); Anees B. Chagpar, MD, MSc, MA, MPH, FACS, FRCS(C), The Society of Surgical Oncology (SSO), William R. Poller, MD, FACR, National Consortium of Breast Centers (NCBC).
ATTRIBUTION TO THE 2013 BREAST CANCER SYMPOSIUM IS REQUESTED IN ALL NEWS COVERAGE.
###
RSS